Page last updated: 2024-09-04

beta-lactams and rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate

beta-lactams has been researched along with rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate in 1 studies

Compound Research Comparison

Studies
(beta-lactams)
Trials
(beta-lactams)
Recent Studies (post-2010)
(beta-lactams)
Studies
(rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate)
Trials
(rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate)
Recent Studies (post-2010) (rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate)
7,5791793,39527015

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavallo, J; Gidenne, S; Hernandez, E; Ramisse, F; van Delden, C1

Other Studies

1 other study(ies) available for beta-lactams and rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate

ArticleYear
Decreased virulence of a strain of Pseudomonas aeruginosa O12 overexpressing a chromosomal type 1 beta-lactamase could be due to reduced expression of cell-to-cell signaling dependent virulence factors.
    FEMS immunology and medical microbiology, 2000, Volume: 28, Issue:3

    Topics: Alginates; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Decanoates; Drug Resistance, Microbial; Endopeptidases; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mice; Mice, Inbred BALB C; Pancreatic Elastase; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rhamnose; Virulence

2000